Want to join the conversation?
$JNJ'S Janssen-Cilag International said Committee for Medicinal Products for Human Use (CHMP) of European Medicines Agency (EMA) has adopted Positive Opinion, recommending broadening existing marketing authorisation for ibrutinib as single agent for treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL).
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?